| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.8M | +5.5% | +99.4% |
| SG&A Expense | $3.1M | +61.5% | +69.8% |
| Operating Income | -$6.0M | -28.9% | -82.7% |
| Pre-tax Income | -$7.3M | -53.3% | -127.2% |
| Net Income | -$7.3M | -53.3% | -127.2% |
| EPS (Basic) | -$1.35 | -23.9% | +26.2% |
| EPS (Diluted) | -$1.35 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.1M | -31.3% | -39.1% |
| Current Assets | $7.4M | -27.3% | -34.5% |
| Total Assets | $10.5M | -21.9% | -22.5% |
| Current Liabilities | $5.9M | -12.6% | +281.3% |
| Total Liabilities | $7.0M | -11.5% | +356.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.6M | — | — |
| Capital Expenditures | $6K | — | — |
| Investing Cash Flow | -$6K | — | — |
| Financing Cash Flow | $7.6M | — | — |
| Free Cash Flow | -$13.7M | — | — |
| -23.9% |
| +26.2% |
| $3.5M |
| -37.0% |
| -71.1% |